Mechanisms of Non-Opsonized Zymosan-Induced and Luminol-Enhanced Chemiluminescence in Whole Blood and Isolated Phagocytes
- 1 January 1987
- journal article
- research article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 25 (11) , 765-778
- https://doi.org/10.1515/cclm.1987.25.11.765
Abstract
A luminol-dependent non-opsonized zymosan-induced chemiluminescence method for phagocytes in small quantities of whole blood (40 .mu.l; final dilution: 1:14) is described. It was characterized with reference to cellular and humoral components, and also applied to isolated neutrophils, eosinophils and monocytes. Normal values for whole blood chemiluminescence and for neutrophils, eosinophils and monocytes are presented. From the chemiluminescence characteristic of distinct phagocytes and their frequency distribution pattern in whole blood, it is concluded that whole blood chemiluminscence has its source predominantly in neutrophils. The question as to the origin of chemiluminescence in phagocytes of whole blood and isolated neutrophils is investigated. The results support the importance of the myeloperoxidase-H2O2-halide system, but also go beyond this. The release of arachidonic acid by phospholipase A2 and of diacylglycerol and inositol trisphosphate by phospholipase C, the metabolism of arachidonic acid by the cyclooxygenase and lipoxyenase pathway, the activation of membrane NADPH oxidase by diacylglycerol and the calcium mobilisation by inositol trisphosphate are necessary for the chemiluminescence reaction. Inhibition of either mechanism suppresses the chemiluminescence response. The interaction of non-opsonized zymosan with plasma opsonins, phagocyte Fc- and complement receptors, respectively, for the initiation of chemiluminesence, was investigated. Non-opsonized zymosan initiates a chemiluminescence response in blood phagocytes in the absence of opsonin from the interaction of the zymosan polysaccharide component glucan with the complement receptor type 3. In the presence of plasma this receptor type also mediates the major chemiluminescence response brought about by the zymosan-coated cleavage products of complement fraction three, iC3b and to a minor degree C3b, while immunoglobulin G-coated zymosan interaction with the Fc-receptors is in this case of minor importance.This publication has 18 references indexed in Scilit:
- Cyclic AMP inhibition of phosphoinositide turnover in human neutrophilsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
- Abnormal erythrocyte and lymphocyte chemiluminescence in chronic granulomatous disease: Evidence for a generalized membrane defectClinical Immunology and Immunopathology, 1986
- Erythrocyte catalase. A somatic oxidant defense?Journal of Clinical Investigation, 1986
- COMPARISON BETWEEN THE LUMINOL‐DEPENDENT CHEMILUMINESCENCE OF POLYMORPHONUCLEAR LEUKOCYTES AND OF THE MYELOPEROXIDASE‐HOOH SYSTEM: INFLUENCE OF pH, CATIONS AND PROTEINPhotochemistry and Photobiology, 1985
- Co-oxidation of luminol by hypochlorite and hydrogen peroxide implications for neutrophil chemiluminescenceBiochemical and Biophysical Research Communications, 1985
- Differences in the effect of arachidonic acid on polymorphonuclear and mononuclear leukocyte functionBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Simultaneous detection of native and luminol-dependent luminescence of stimulated human polymorphonuclear leukocytesBiochemical and Biophysical Research Communications, 1984
- Intact human erythrocytes prevent hydrogen peroxide-mediated damage to isolated perfused rat lungs and cultured bovine pulmonary artery endothelial cells.Journal of Clinical Investigation, 1984
- Regulation of the Human Polymorphonuclear Leukocyte Inflammatory Response by Inhibitors of Arachidonic Acid MetabolismJournal of Immunopharmacology, 1984
- Measurement of chemiluminescence in freshly drawn human bloodJournal of Molecular Medicine, 1982